Immunology
Liza Laquian, MD (she/her/hers)
University of Florida, Florida
Disclosure(s): No relevant financial relationship(s) to disclose.
One in eight critically ill patients report alcohol use disorder (AUD). The incidence has increased further since the COVID-19 pandemic. AUD is an independent risk factor for sepsis and acute respiratory distress syndrome mortality. Emerging evidence suggests that alcohol exposure regulates immune response and impairs pathogen clearance. Alcohol also damages intestinal epithelial barrier function, which further fuels the dysregulation of immune response in critically ill patients. The goal of this session is to discuss how AUD fundamentally changes the immune response in critical illness and how research is needed to address this clinically important patient population.
Vidula Vachharajani, MD, FCCP, FCCM – Cleveland Clinic Lerner College of Medicine
Craig Coopersmith, MD, MCCM (he/him/his) – Emory University Hospital
Jamie L. Sturgill, PhD (she/her/hers) – University of Kentucky